These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27302165)

  • 1. Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth.
    Cormerais Y; Giuliano S; LeFloch R; Front B; Durivault J; Tambutté E; Massard PA; de la Ballina LR; Endou H; Wempe MF; Palacin M; Parks SK; Pouyssegur J
    Cancer Res; 2016 Aug; 76(15):4481-92. PubMed ID: 27302165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
    Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
    J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle.
    Drummond MJ; Glynn EL; Fry CS; Timmerman KL; Volpi E; Rasmussen BB
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1011-8. PubMed ID: 20304764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling.
    Nagamori S; Wiriyasermkul P; Okuda S; Kojima N; Hari Y; Kiyonaka S; Mori Y; Tominaga H; Ohgaki R; Kanai Y
    Amino Acids; 2016 Apr; 48(4):1045-1058. PubMed ID: 26724922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting glutamine transport to suppress melanoma cell growth.
    Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JE; Holst J
    Int J Cancer; 2014 Sep; 135(5):1060-71. PubMed ID: 24531984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.
    Ohshima Y; Kaira K; Yamaguchi A; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Yokobori T; Miyazaki T; Asao T; Tsushima Y; Kuwano H; Ishioka NS
    Cancer Sci; 2016 Oct; 107(10):1499-1505. PubMed ID: 27465934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
    Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral modulation of the tumor-associated system L amino acid transporter, LAT1, alters amino acid transport, cell growth and 4F2/CD98 expressionwith cell-type specific effects in cultured hepatic cells.
    Storey BT; Fugere C; Lesieur-Brooks A; Vaslet C; Thompson NL
    Int J Cancer; 2005 Nov; 117(3):387-97. PubMed ID: 15900591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter.
    Napolitano L; Scalise M; Galluccio M; Pochini L; Albanese LM; Indiveri C
    Int J Biochem Cell Biol; 2015 Oct; 67():25-33. PubMed ID: 26256001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells.
    Le Vee M; Jouan E; Lecureur V; Fardel O
    Toxicol Appl Pharmacol; 2016 Jan; 290():74-85. PubMed ID: 26621329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
    Milkereit R; Persaud A; Vanoaica L; Guetg A; Verrey F; Rotin D
    Nat Commun; 2015 May; 6():7250. PubMed ID: 25998567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The catalytic subunit of the system L1 amino acid transporter (slc7a5) facilitates nutrient signalling in mouse skeletal muscle.
    Poncet N; Mitchell FE; Ibrahim AF; McGuire VA; English G; Arthur JS; Shi YB; Taylor PM
    PLoS One; 2014; 9(2):e89547. PubMed ID: 24586861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular signaling of amino acids towards mTORC1 activation in impaired human leucine catabolism.
    Schriever SC; Deutsch MJ; Adamski J; Roscher AA; Ensenauer R
    J Nutr Biochem; 2013 May; 24(5):824-31. PubMed ID: 22898570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Ablation of LAT1 Inhibits Growth of Liver Cancer Cells and Downregulates mTORC1 Signaling.
    Kim SY; Ong Q; Liao Y; Ding Z; Tan AQL; Lim LTR; Tan HM; Lim SL; Lee QY; Han W
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
    Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
    Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma.
    Cormerais Y; Pagnuzzi-Boncompagni M; Schrötter S; Giuliano S; Tambutté E; Endou H; Wempe MF; Pagès G; Pouysségur J; Picco V
    J Cell Mol Med; 2019 Apr; 23(4):2711-2718. PubMed ID: 30784173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications.
    Kahlhofer J; Teis D
    Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):459-472. PubMed ID: 36460306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts.
    Campbell WA; Thompson NL
    J Biol Chem; 2001 May; 276(20):16877-84. PubMed ID: 11278397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin enhances anti-tumor effect of L-type amino acid transporter 1 (LAT1) inhibitor.
    Ueno S; Kimura T; Yamaga T; Kawada A; Ochiai T; Endou H; Sakurai H
    J Pharmacol Sci; 2016 Jun; 131(2):110-7. PubMed ID: 27262901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.
    Saito S; Ando K; Sakamoto S; Xu M; Yamada Y; Rii J; Kanaoka S; Wei J; Zhao X; Pae S; Kanesaka M; Goto Y; Sazuka T; Imamura Y; Reien Y; Hamaguchi-Suzuki N; Saito S; Hirayama Y; Hashimoto H; Kanai Y; Ichikawa T; Anzai N
    Cancer Sci; 2024 Jul; 115(7):2461-2472. PubMed ID: 38655663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.